American Society of Clinical Oncology 47th Annual Meeting Meeting Program Note: Sessions in which Special Awards are presented are shaded in gray Friday, June 3, 2011 1:00 PM - 2:15 PM FRIDAY EDUCATION SESSIONS Customized Cancer Treatment: A Systems Biology Approach to Drug Selection Location: E354b CME credit: 1.25 Track(s): Developmental Therapeutics, Cancer Genetics, Clinical Trials John Mendelsohn, MD—Chair University of Texas M. D. Anderson Cancer Center Customized Cancer Medicine: Are We Ready for What It Will Take? Jeffrey M. Trent, PhD TGen Large-scale, Multidimensional Genomics Data: Making Sense for Patients Andrea Califano, PhD Columbia University Cancer’s Complexity: Are We Looking at the Wrong Levels to Develop Effective Interventions? Endometrial Cancer: Present State and Future Promise Location: E354a CME credit: 1.25 Track(s): Gynecologic Cancer Don S. Dizon, MD—Chair Warren Alpert Medical School of Brown University Options in the Treatment of Relapsed Endometrial Cancer: Beyond First-line Therapy Karen H. Lu, MD University of Texas M. D. Anderson Cancer Center Molecular Characterization of Endometrial Cancer: Going beyond Histology David Scott Miller, MD University of Texas Southwestern Medical Center Incorporation of Adjuvant Chemotherapy into Endometrial Cancer Treatment Neoadjuvant Therapy in Operable Breast Cancer: Who, What, When, Why, and How? Location: Hall D1 CME credit: 1.25 Track(s): Breast Cancer Luca Gianni, MD—Chair Fondazione IRCCS Istituto Nazionale dei Tumori Neoadjuvant Assumptions and Application to Chemotherapy, Endocrine Therapy, and Biologic Therapy-based Regimens David W. Ollila, MD University of North Carolina at Chapel Hill Surgical Implications of the Neoadjuvant Approach: Facilitating Research Biopsies, Breast Conservation in Previously T3–4 Tumors, and Axillary Staging—Before or After? Thomas A. Buchholz, MD University of Texas M. D. Anderson Cancer Center Radiation in the Setting of Marked Cytoreduction: Do We Radiate a Cleared Nodal Basin or Breast? 58 Friday, June 3, 2011 Pediatric Bone Sarcomas: Converging Progress on the Biologic and Clinical Fronts? Location: S504 CME credit: 1.25 Track(s): Pediatric Oncology, Sarcoma FRIDAY Stephen L. Lessnick, MD, PhD—Chair Huntsman Cancer Institute Recent Progress in Understanding the Biology of Bone Tumors Holcombe E. Grier, MD Dana-Farber Cancer Institute Advances in the Treatment of Ewing’s Sarcoma Neyssa Marina, MD Stanford University School of Medicine Update on the Management of Children, Adolescents, and Young Adults with Osteosarcoma Radiation Therapy Updates for Primary Brain Tumors: Clinical Role for Proton Therapy, Stereotactic Radiosurgery, and Hypofractionated Schedules Location: S100bc CME credit: 1.25 Track(s): Central Nervous System Tumors John H. Suh, MD—Chair Cleveland Clinic Radiosurgery Applications for Primary Brain Tumors Eugen Hug, MD Paul Scherrer Institut Proton Therapy for Primary Brain Tumors: When to Refer Eric L. Chang, MD University of Texas M. D. Anderson Cancer Center Abbreviated Course of Radiation Therapy in Older Patients with Glioblastoma Survivorship Care: Whose Job Is It? Location: S406 CME credit: 1.25 Track(s): Patient and Survivor Care, Health Services Research Julia Howe Rowland, PhD—Chair National Cancer Institute/National Institutes of Health Overview of This Emerging Challenge in Survivors’ Care Paul Han, MD, MA, MPH Maine Medical Center Research Institute Presentation of Data from the National Cancer Institute– and American Cancer Society–funded Study: Survey of Physician Attitudes Regarding Care of Cancer Survivors James Ross Waisman, MD Breastlink Medical Group Inc. How to Implement Survivorship Care in Practice 59 Friday, June 3, 2011 The Identification and Treatment of the “High Risk” Patient with Non-Hodgkin FRIDAY Lymphoma and Myeloma Location: Arie Crown Theater CME credit: 1.25 Track(s): Lymphoma and Plasma Cell Disorders Francine M. Foss, MD—Chair Yale Cancer Center High-risk Peripheral T-cell Lymphoma Michael Pfreundschuh, MD Saarland University Hospital High-risk B-cell Non-Hodgkin Lymphoma Rafael Fonseca, MD Mayo Clinic High-risk Myeloma 60 Friday, June 3, 2011 1:00 PM - 2:15 PM MEET THE PROFESSOR SESSION Implementing a Quality Research Program in a Community Setting (M05)—Ticketed Session Location: E451a FRIDAY CME credit: 1.25 Track(s): Clinical Trials, Practice Management and Information Technology, Professional Development Patrick J. Flynn, MD Metro Minnesota Community Clinical Oncology Project Practical Aspects of Clinical Trial Implementation in the Community Setting Lidia Schapira, MD Massachusetts General Hospital Talking to Patients about Clinical Trials 61 Friday, June 3, 2011 1:00 PM - 3:15 PM FRIDAY EXTENDED EDUCATION SESSIONS How to Participate in Clinical Research across Borders Location: S100a CME credit: 2.25 Track(s): Clinical Trials, International Eduardo L. Cazap, MD—Chair Latin American-Caribbean Society of Medical Oncology Martine J. Piccart-Gebhart, MD, PhD Jules Bordet Institute The BIG Experience: Challenges and Opportunities Edward Lloyd Trimble, MD National Cancer Institute Promoting Independent Research at the U.S. National Cancer Institute Jean-Yves Blay, MD, PhD Centre Le´onBe´rard How to Participate in European Organisation for Research and Treatment of Cancer Trials Henry Leonidas Gomez, MD Instituto Nacional de Enfermedades Neoplasicas Leading Clinical Research in Low-resource Scenarios Role of Nutrition, Supplements, and Integrative Medicine in Cancer Prevention, Treatment, and Survivorship Location: E353 CME credit: 2.25 Track(s): Cancer Prevention/Epidemiology, General Oncology, Patient and Survivor Care Charles L. Loprinzi, MD—Chair Mayo Clinic Nutrition Recommendations for Patients with Far-advanced Disease Heather Greenlee, ND, PhD Columbia University Lifestyle Modification and Dietary Supplements in Cancer Prevention: What Is the Role? Kimberly Robien, PhD, RD University of Minnesota Approaches to Nutrition Interventions during Cancer Treatment Wendy Demark-Wahnefried, PhD, RD University of Alabama at Birmingham Nutrition and Physical Activity Recommendations for Cancer Survivorship: What Do We Tell Our Patients and Their Families after Treatment? Lorenzo Cohen, PhD University of Texas M. D. Anderson Cancer Center Improving Patient Outcomes: The Role of Integrative Medicine in Cancer Care 62 Friday, June 3, 2011 1:00 PM - 3:30 PM EXTENDED EDUCATION SESSIONS Grant Writing Workshop I: Basic Grant Writing Location: S106 CME credit: 2.5 FRIDAY Track(s): Professional Development, Clinical Trials Charles M. Rudin, MD, PhD—Chair The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Developing Hypothesis and Stating Aims Lei Ming, PhD National Cancer Institute National Cancer Institute Training and Career Development Grants Kathleen A. Cooney, MD University of Michigan Medical School, University of Michigan Comprehensive Cancer Center Conquer Cancer Foundation of ASCO (formerly The ASCO Cancer Foundation) Grants Program Susan Blaney, MD Texas Children’s Cancer Center Choosing a Mentor and Obtaining Letters of Support Heidi Nelson, MD Mayo Clinic Tips for Grant Writing in the New National Institutes of Health Format Donna S. Neuberg, ScD Dana-Farber Cancer Institute Statistical Considerations Mary L. Disis, MD University of Washington Grant Writing Pearls On the Shoulders of Giants: Historical Perspectives on Biomarkers and Colorectal Carcinoma Location: E350 CME credit: 2.5 Track(s): Professional Development, Gastrointestinal (Colorectal) Cancer Jill Gilbert, MD—Chair Vanderbilt University Robert J. Mayer, MD Dana-Farber Cancer Institute History of Systemic Treatment for Colorectal Cancer S. Gail Eckhardt, MD University of Colorado School of Medicine, Anschutz Medical Campus History of the Development of Novel Agents and Integration of Biomarkers in Colorectal Cancer Katherine Elizabeth Reeder-Hayes, MD University of North Carolina Hospital Case Study: Colorectal Carcinoma Jae Hong Park, MD Memorial Sloan-Kettering Cancer Center Case Study: Colorectal Carcinoma 63 Friday, June 3, 2011 1:00 PM - 4:00 PM FRIDAY EXTENDED EDUCATION SESSION Maintenance of Certification and Lifelong Learning Workshop (MOC)—Ticketed Session Location: E451b Track(s): Professional Development Alexandria T. Phan, MD—Chair University of Texas M. D. Anderson Cancer Center ABIM 2010 Update in Medical Oncology Gregory A. Masters, MD Thomas Jefferson University Medical School and Medical Oncology Hematology Consultants ABIM 2010 Update in Medical Oncology Anne Moore, MD Weill Cornell Medical College ABIM 2010 Update in Medical Oncology 64 Friday, June 3, 2011 2:00 PM - 6:00 PM POSTER DISCUSSION SESSION Central Nervous System Tumors Display Time: 2:00 PM - 6:00 PM Display Location: S102 FRIDAY Discussion Time: 5:00 PM - 6:00 PM Discussion Location: S100a CME credit: 1 Track(s): Central Nervous System Tumors Mark R. Gilbert, MD—Co-Chair University of Texas M. D. Anderson Cancer Center John L. Villano, MD—Co-Chair University of Illinois Discussion 5:00 PM Martin Kelly Nicholas, MD, PhD (Abstracts #2012–2017) The University of Chicago Discussion 5:30 PM Jeffrey J. Raizer, MD (Abstracts #2025–2030) Northwestern University Feinberg School of Medicine Discussion 5:45 PM David M. Peereboom, MD (Abstracts #2031–2036) Cleveland Clinic Brd. 1 A population-based study of glioblastoma multiforme (GBM) in the new Stupp paradigm: Have we improved outcome? (Abstract #2012) Z. Lwin, D. MacFadden, A. AL-Zahrani, E. Atenafu, B. Miller, C. Menard, N. Laperriere, W. P. Mason Brd.